Colleen Baldwin | Ms. Baldwin has been president of Connecticut-based consultancy Glantuam Partners, LLC since 2005. A dual citizen of the U.S. and Ireland, she is an experienced COO and independent board director, serving as a director for both Voya Mutual Funds Group and Dentaquest. Her industry expertise is in global asset management and mutual funds, banking, insurance, technology, and healthcare. Baldwin is a qualified financial expert.
J. Thomas Bowler, Jr. | Mr. Bowler was senior vice president, human resources and organization at United Technologies Corporation. Bowler joined United Technologies in 1979 at the corporation’s Pratt & Whitney unit. He held the senior human resources positions at Pratt & Whitney and Carrier, and previously held executive positions at Carrier’s Asia Pacific Operations, Hamilton Sundstrand, and the former UT Automotive. Bowler joined United Technologies’ corporate office as vice president, human resources, in May 2006. He completed his undergraduate studies at the University of Massachusetts at Amherst and received his master’s degree from Harvard University.
Jonathan J. Bush | Mr. Bush is senior managing director at Fairfield, Bush, & Co. He is a graduate of Yale University (BA) and New York University School of Business (MBA). Bush is former chairman of the board of The United Negro College Fund and chaired the UNCF Capital Campaign which raised two hundred and eighty million dollars. He is a former board member of Russell Reynolds Associates, The Baltimore Orioles, The Yale Alumni Fund, The Boys Club of New York, Miss Porter’s School and held the position of Finance Chairman of the New York Republican party. A former member of the Board of Yale New Haven Hospital, Bush served as co-chairman of the Smilow Cancer Hospital Capital Campaign. He holds honorary degrees from Buthune-Cookman College, St. Augustine’s College, and Stillman College.
Andreas Fibig | Mr. Fibig joined International Flavors & Fragrances’ Board in 2011 and has been the company’s chairman since December 2014 and CEO since September 2014. Previously, he served as president and chairman of the board of management of Bayer HealthCare Pharmaceuticals, the pharmaceutical division of Bayer AG, from September 2008 to September 2014. Prior to that position, Fibig held a number of positions of increasing responsibility at Pfizer. Fibig’s prior work experience with various pharmaceutical companies has provided him with extensive experience in international business, product development, and strategic planning. He chairs the Board of Trustees of the Max Planck Institute for Infection Biology. Fibig also serves on the board of Bunge Limited.
L. Scott Frantz | Mr. Frantz is president of Haebler Capital, a private investment company in Greenwich, Connecticut, with interests in private and public equity markets, venture capital, the specialty coffee import business, and industrial privatization in emerging markets. He also serves as a Connecticut state senator for the state’s 36th District, having been first elected in 2008. Frantz is chairman of the Bradley International Airport Executive Board, chairman of the Connecticut Development Authority, a director of Haebler Capital, Marina America, Inc. and S&T Development. He also serves on the following non-profit boards and councils: AmeriCares, Greenwich Teen Center, International House, Connecticut Republican Finance Committee, American Everest Foundation, and the Veterans Appreciation Council.
Edward A. Kangas | Mr. Kangas served as Global Chairman and Chief Executive Officer of Deloitte Touche Tohmatsu from 1989 to 2000. Under his leadership the firm’s revenues grew to $11 billion in 2000 from $2 billion in 1989. He was one of the chief architects of the 1989 global combination of Deloitte Haskins & Sells and Touche Ross. A Certified Public Accountant, Kangas holds a bachelor’s degree and an MBA from the University of Kansas. He serves on the boards of United Technologies, Eclipsys Corporation, Hovnanian Enterprises Inc., Intuit Inc., Network Solutions and Tenet Healthcare Corporation. At Tenet, Kangas has served as Non-Executive Chairman of the Board since July 2003. Kangas is currently a member of the board of trustees of the University of Kansas Endowment Association and a member of the University of Kansas Business School Advisors, and he has served as a member of the board of overseers of The Wharton School at the University of Pennsylvania.
Christopher K. Kay | Mr. Kay serves as president and chief executive officer of the New York Racing Association (NYRA). Before joining NYRA, Kay served as chief operating officer for The Trust for Public Land, where he oversaw the operations of the land conservation organization’s headquarters and 37 field offices. Prior to that, he was a consultant to Universal Parks and Resorts, serving as its managing director of international business development. From 2001 – 2006, Kay served as chief operating officer for Toys ‘R’ Us, a Fortune 200 international company, and prior to that he was the retailer’s executive vice president of operations and general counsel. Kay was also a minority owner of Orlando’s AA baseball team and a member of the ownership group that sought to obtain the first Major League Baseball franchise in Florida. He is a graduate of the University of Missouri and of the Duke University School of Law.
James W. Kinnear | Mr. Kinnear is the former president and CEO of Texaco, Inc. Kinnear served as a director of the Saudi Arabian Oil Company (Saudi Aramco). Earlier he was a director of Aramco Inc., Corning Incorporated, Paine Webber Group Inc., an advisory director of Unilever PLC and Unilever N.V. and chairman of the Metropolitan Opera Association and the Veterans Appreciation Council.
Akira Matsumoto | Mr. Matsumoto serves as chairman and chief executive officer of Calbee Japan, a leading snack food maker headquartered in Tokyo. He is widely-considered one of the most influential CEOs in Japan. He has both Japanese and foreign capital company experience, serving as CEO at both Johnson & Johnson Japan and Calbee. In 1972, he joined ITOCHU Corporation and in 1993 was appointed representative director and general manager of the Ethicon Endo-Surgery business division of Johnson & Johnson Medical Company.